Companion Animal Diagnostics Market By Technology (Clinical Biochemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Other Applications), By Animal Type (Dogs, Cats, Others), By End User (Diagnostic Labs, Veterinary Hospitals and Clinics, Point-Of-Care and In-House Testing, Research Institutes and Universities): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global companion animal diagnostics market was valued at $2,989.8 million in 2021, and is projected to reach $6,884.67 million by 2031, registering a CAGR of 8.6% from 2022 to 2031.
Companion animal diagnostics is a diagnostic method that is used to identify a chronic disease in companion animals at the molecular level. Companion animal diagnosis is considered to be the best method to identify & characterize various chronic diseases in animals. For the detection of diseases, several diagnostics method are used such as molecular diagnostic, immunodiagnostic, Clinical biochemistry, uranalysis and among others.
The key factors that drive the growth of the market are an increase in animal healthcare expenditure, rise in pet adoption, and an increase in the prevalence of chronic diseases such as zoonotic disease cancer, gastrointestinal disease, and others. For instance, according to a report published by the Center for Disease Control and Prevention, zoonotic diseases are very common, both in the United States and around the world and it was estimated that about 6 out of every 10 animal is affected by a zoonotic disease. Furthermore, the rise in awareness associated with animal healthcare, and the rise in the adoption of rapid tests and portable instruments for point-of-care diagnostics are the key factors that provide lucrative opportunities for key industry players. However, the lack of skilled veterinary professionals and animal health awareness hinders the growth of the market in upcoming years.
The companion animal diagnostics market is segmented on the basis of technology, application, animal type, end-use, and region. By technology, the market is segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others. The basis of clinical biochemistry is further sub-segmented into clinical chemistry analyzers, blood gas & electrolyte analysis, and glucose monitoring. Immunodiagnostics is sub-segmented into ELISA, lateral flow assay, immunoassay analyzer, and other (rapid test, western blot tests, immunohistochemistry, allergen-specific immunodiagnostic tests diagnostics). Hematology is further bifurcated into hematology cartridges and hematology analyzers. Molecular diagnostics is sub-segmented into PCR, microarray, and others. Urinalysis is sub-segmented into urinalysis clips & cartridges/panels, urine analyzers, and urine test strips. And on the basis of others, the technology market for companion animal diagnostics is bifurcated into microbiology tests and histopathology tests. On the basis of application, the market is segmented into bacteriology, clinical pathology, virology, parasitology, and others. On the basis of animal type, the market is bifurcated into dogs, cats, and others. By end use, the market is segmented into diagnostics laboratories, veterinary healthcare and clinics, research institute, and point of care. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for the largest market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to rise in the adoption of pets in North America and the rise in the prevalence of various chronic diseases among animals drive the growth of the companion animal diagnostics market. Asia-Pacific is anticipated to witness lucrative growth, owing to a surge in the companion animal population, growing demand for diagnostics services from the livestock industry, and rise in companion animal health expenditure among emerging countries across APAC is expected to offer significant growth for the market
The key players that operate in the companion animal diagnostics market are Agrolabo SpA, Biomerieux SA, BioNote Inc. Creative Diagnostics, Fujifilm Holdings Corporation, Heska Corporation, HyTest Ltd., Idexx Laboratories Inc., IDvet, Indical Bioscience Gmbh, Neogen Corporation, Randox Laboratories Ltd., Shenzhen Mindray Animal Medical Technology Co. Ltd, Thermofisher Scientifc Inc., Triviumvet, Virbac and Zoetis Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the companion animal diagnostics market analysis from 2021 to 2031 to identify the prevailing companion animal diagnostics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the companion animal diagnostics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global companion animal diagnostics market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Technology
Clinical Biochemistry
Clinical Chemistry Analyzer
Blood Glucose Monitoring
Blood Gas Electrolyte Analysis
Immunodiagnostics
ELISA
Lateral Flow Assay
Immunoassay Analyzers
Others
Hematology
Hematology Cartridges
Hematology Analyzers
Molecular Diagnostics
PCR
Microarrays
Others
Urinalysis
Urinalysis clips cartridges/panels
Urine Analyzer
Urine Test Strips
Others
By Application
Clinical Pathology
Bacteriology
Virology
Parasitology
Other Applications
By Animal Type
Dogs
Cats
Others
By End User
Diagnostic Labs
Point-Of-Care and In-House Testing
Research Institutes and Universities
Veterinary Hospitals and Clinics
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Virbac
Thermo Fisher Scientific, Inc
Zoetis, Inc
agrolabo spa
Biomerieux SA
BioNote Inc
Creative Diagnostics
Fujifilm Holdings Corporation
Heska Corporation
HyTest Ltd
Idexx Laboratories Inc
IDvet
Indical Bioscience Gmbh
Neogen Corporation
Randox Laboratories Ltd
Shenzhen Mindray Animal Medical Technology Co. Ltd
Triviumvet
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Clinical Biochemistry
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Immunodiagnostics
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Molecular Diagnostics
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Hematology
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Urinalysis
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- 4.7 Others
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
- CHAPTER 5: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Clinical Pathology
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Bacteriology
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Virology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Parasitology
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Other Applications
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- CHAPTER 6: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Dogs
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Cats
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Diagnostic Labs
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Veterinary Hospitals and Clinics
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Point-Of-Care and In-House Testing
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
- 7.5 Research Institutes and Universities
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country
- CHAPTER 8: COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Technology
- 8.2.3 North America Market size and forecast, by Application
- 8.2.4 North America Market size and forecast, by Animal Type
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Technology
- 8.2.6.1.2 Market size and forecast, by Application
- 8.2.6.1.3 Market size and forecast, by Animal Type
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Technology
- 8.2.6.2.2 Market size and forecast, by Application
- 8.2.6.2.3 Market size and forecast, by Animal Type
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Technology
- 8.2.6.3.2 Market size and forecast, by Application
- 8.2.6.3.3 Market size and forecast, by Animal Type
- 8.2.6.3.4 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Technology
- 8.3.3 Europe Market size and forecast, by Application
- 8.3.4 Europe Market size and forecast, by Animal Type
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Technology
- 8.3.6.1.2 Market size and forecast, by Application
- 8.3.6.1.3 Market size and forecast, by Animal Type
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Technology
- 8.3.6.2.2 Market size and forecast, by Application
- 8.3.6.2.3 Market size and forecast, by Animal Type
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 U.K.
- 8.3.6.3.1 Market size and forecast, by Technology
- 8.3.6.3.2 Market size and forecast, by Application
- 8.3.6.3.3 Market size and forecast, by Animal Type
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Market size and forecast, by Technology
- 8.3.6.4.2 Market size and forecast, by Application
- 8.3.6.4.3 Market size and forecast, by Animal Type
- 8.3.6.4.4 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Technology
- 8.3.6.5.2 Market size and forecast, by Application
- 8.3.6.5.3 Market size and forecast, by Animal Type
- 8.3.6.5.4 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Technology
- 8.3.6.6.2 Market size and forecast, by Application
- 8.3.6.6.3 Market size and forecast, by Animal Type
- 8.3.6.6.4 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Technology
- 8.4.3 Asia-Pacific Market size and forecast, by Application
- 8.4.4 Asia-Pacific Market size and forecast, by Animal Type
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 Japan
- 8.4.6.1.1 Market size and forecast, by Technology
- 8.4.6.1.2 Market size and forecast, by Application
- 8.4.6.1.3 Market size and forecast, by Animal Type
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 China
- 8.4.6.2.1 Market size and forecast, by Technology
- 8.4.6.2.2 Market size and forecast, by Application
- 8.4.6.2.3 Market size and forecast, by Animal Type
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 Australia
- 8.4.6.3.1 Market size and forecast, by Technology
- 8.4.6.3.2 Market size and forecast, by Application
- 8.4.6.3.3 Market size and forecast, by Animal Type
- 8.4.6.3.4 Market size and forecast, by End User
- 8.4.6.4 India
- 8.4.6.4.1 Market size and forecast, by Technology
- 8.4.6.4.2 Market size and forecast, by Application
- 8.4.6.4.3 Market size and forecast, by Animal Type
- 8.4.6.4.4 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Market size and forecast, by Technology
- 8.4.6.5.2 Market size and forecast, by Application
- 8.4.6.5.3 Market size and forecast, by Animal Type
- 8.4.6.5.4 Market size and forecast, by End User
- 8.4.6.6 Rest Of Asia Pacific
- 8.4.6.6.1 Market size and forecast, by Technology
- 8.4.6.6.2 Market size and forecast, by Application
- 8.4.6.6.3 Market size and forecast, by Animal Type
- 8.4.6.6.4 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Technology
- 8.5.3 LAMEA Market size and forecast, by Application
- 8.5.4 LAMEA Market size and forecast, by Animal Type
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Technology
- 8.5.6.1.2 Market size and forecast, by Application
- 8.5.6.1.3 Market size and forecast, by Animal Type
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Technology
- 8.5.6.2.2 Market size and forecast, by Application
- 8.5.6.2.3 Market size and forecast, by Animal Type
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 South Africa
- 8.5.6.3.1 Market size and forecast, by Technology
- 8.5.6.3.2 Market size and forecast, by Application
- 8.5.6.3.3 Market size and forecast, by Animal Type
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Market size and forecast, by Technology
- 8.5.6.4.2 Market size and forecast, by Application
- 8.5.6.4.3 Market size and forecast, by Animal Type
- 8.5.6.4.4 Market size and forecast, by End User
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 Virbac
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Thermo Fisher Scientific, Inc
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Zoetis, Inc
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 agrolabo spa
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Biomerieux SA
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 BioNote Inc
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 Creative Diagnostics
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 Fujifilm Holdings Corporation
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Heska Corporation
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 HyTest Ltd
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- 10.11 Idexx Laboratories Inc
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
- 10.12 IDvet
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
- 10.13 Indical Bioscience Gmbh
- 10.13.1 Company overview
- 10.13.2 Company snapshot
- 10.13.3 Operating business segments
- 10.13.4 Product portfolio
- 10.13.5 Business performance
- 10.13.6 Key strategic moves and developments
- 10.14 Neogen Corporation
- 10.14.1 Company overview
- 10.14.2 Company snapshot
- 10.14.3 Operating business segments
- 10.14.4 Product portfolio
- 10.14.5 Business performance
- 10.14.6 Key strategic moves and developments
- 10.15 Randox Laboratories Ltd
- 10.15.1 Company overview
- 10.15.2 Company snapshot
- 10.15.3 Operating business segments
- 10.15.4 Product portfolio
- 10.15.5 Business performance
- 10.15.6 Key strategic moves and developments
- 10.16 Shenzhen Mindray Animal Medical Technology Co. Ltd
- 10.16.1 Company overview
- 10.16.2 Company snapshot
- 10.16.3 Operating business segments
- 10.16.4 Product portfolio
- 10.16.5 Business performance
- 10.16.6 Key strategic moves and developments
- 10.17 Triviumvet
- 10.17.1 Company overview
- 10.17.2 Company snapshot
- 10.17.3 Operating business segments
- 10.17.4 Product portfolio
- 10.17.5 Business performance
- 10.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 2. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR CLINICAL BIOCHEMISTRY, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL BIOCHEMISTRY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR IMMUNODIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. COMPANION ANIMAL DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR MOLECULAR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. COMPANION ANIMAL DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR HEMATOLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. COMPANION ANIMAL DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 10. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR URINALYSIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. COMPANION ANIMAL DIAGNOSTICS MARKET FOR URINALYSIS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 12. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 14. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 15. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR CLINICAL PATHOLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR BACTERIOLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 19. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR VIROLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR PARASITOLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR OTHER APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 26. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR DOGS, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR CATS, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 32. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 33. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR DIAGNOSTIC LABS, BY REGION, 2021-2031 ($MILLION)
- TABLE 34. COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 35. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR VETERINARY HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 36. COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 37. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR POINT-OF-CARE AND IN-HOUSE TESTING, BY REGION, 2021-2031 ($MILLION)
- TABLE 38. COMPANION ANIMAL DIAGNOSTICS MARKET FOR POINT-OF-CARE AND IN-HOUSE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 39. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR RESEARCH INSTITUTES AND UNIVERSITIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 40. COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES AND UNIVERSITIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 41. COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 42. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 43. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 44. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 45. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 46. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 47. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 48. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 49. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 50. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 51. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 52. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 53. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 54. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 55. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 56. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 57. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 58. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 59. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 60. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 61. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 62. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 63. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 64. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 65. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 66. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 67. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 68. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 69. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 70. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 71. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 73. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 74. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 75. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 76. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 77. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 78. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 79. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 80. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 81. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 82. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 83. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 85. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 86. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 87. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 88. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 89. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 90. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 91. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 92. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 93. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 94. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 95. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 96. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 97. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 98. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 99. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 100. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 101. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 102. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 103. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 104. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 105. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 106. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 107. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 108. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 109. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 110. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 111. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 112. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 113. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 114. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 115. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 116. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 117. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 118. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 119. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 120. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 121. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 122. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 123. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 124. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 125. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 126. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 127. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 128. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 129. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 130. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 131. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 132. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 133. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 134. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
- TABLE 135. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 136. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
- TABLE 137. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 138.VIRBAC: COMPANY SNAPSHOT
- TABLE 139.VIRBAC: OPERATING SEGMENTS
- TABLE 140.VIRBAC: PRODUCT PORTFOLIO
- TABLE 141.VIRBAC: NET SALES,
- TABLE 142.VIRBAC: KEY STRATERGIES
- TABLE 143.THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
- TABLE 144.THERMO FISHER SCIENTIFIC, INC: OPERATING SEGMENTS
- TABLE 145.THERMO FISHER SCIENTIFIC, INC: PRODUCT PORTFOLIO
- TABLE 146.THERMO FISHER SCIENTIFIC, INC: NET SALES,
- TABLE 147.THERMO FISHER SCIENTIFIC, INC: KEY STRATERGIES
- TABLE 148.ZOETIS, INC: COMPANY SNAPSHOT
- TABLE 149.ZOETIS, INC: OPERATING SEGMENTS
- TABLE 150.ZOETIS, INC: PRODUCT PORTFOLIO
- TABLE 151.ZOETIS, INC: NET SALES,
- TABLE 152.ZOETIS, INC: KEY STRATERGIES
- TABLE 153.AGROLABO SPA: COMPANY SNAPSHOT
- TABLE 154.AGROLABO SPA: OPERATING SEGMENTS
- TABLE 155.AGROLABO SPA: PRODUCT PORTFOLIO
- TABLE 156.AGROLABO SPA: NET SALES,
- TABLE 157.AGROLABO SPA: KEY STRATERGIES
- TABLE 158.BIOMERIEUX SA: COMPANY SNAPSHOT
- TABLE 159.BIOMERIEUX SA: OPERATING SEGMENTS
- TABLE 160.BIOMERIEUX SA: PRODUCT PORTFOLIO
- TABLE 161.BIOMERIEUX SA: NET SALES,
- TABLE 162.BIOMERIEUX SA: KEY STRATERGIES
- TABLE 163.BIONOTE INC: COMPANY SNAPSHOT
- TABLE 164.BIONOTE INC: OPERATING SEGMENTS
- TABLE 165.BIONOTE INC: PRODUCT PORTFOLIO
- TABLE 166.BIONOTE INC: NET SALES,
- TABLE 167.BIONOTE INC: KEY STRATERGIES
- TABLE 168.CREATIVE DIAGNOSTICS: COMPANY SNAPSHOT
- TABLE 169.CREATIVE DIAGNOSTICS: OPERATING SEGMENTS
- TABLE 170.CREATIVE DIAGNOSTICS: PRODUCT PORTFOLIO
- TABLE 171.CREATIVE DIAGNOSTICS: NET SALES,
- TABLE 172.CREATIVE DIAGNOSTICS: KEY STRATERGIES
- TABLE 173.FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
- TABLE 174.FUJIFILM HOLDINGS CORPORATION: OPERATING SEGMENTS
- TABLE 175.FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO
- TABLE 176.FUJIFILM HOLDINGS CORPORATION: NET SALES,
- TABLE 177.FUJIFILM HOLDINGS CORPORATION: KEY STRATERGIES
- TABLE 178.HESKA CORPORATION: COMPANY SNAPSHOT
- TABLE 179.HESKA CORPORATION: OPERATING SEGMENTS
- TABLE 180.HESKA CORPORATION: PRODUCT PORTFOLIO
- TABLE 181.HESKA CORPORATION: NET SALES,
- TABLE 182.HESKA CORPORATION: KEY STRATERGIES
- TABLE 183.HYTEST LTD: COMPANY SNAPSHOT
- TABLE 184.HYTEST LTD: OPERATING SEGMENTS
- TABLE 185.HYTEST LTD: PRODUCT PORTFOLIO
- TABLE 186.HYTEST LTD: NET SALES,
- TABLE 187.HYTEST LTD: KEY STRATERGIES
- TABLE 188.IDEXX LA
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook